FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063600286> ?p ?o ?g. }

• W2063600286 abstract "Patients with Hodgkin's disease (HD) refractory to first line chemotherapy and those who have rapid or multiple relapses have a very poor prognosis. With the increasing use of hybrid chemotherapy these patients will have been exposed to many of the drugs active in HD so it is important to develop salvage regimens that are novel and demonstrate activity in this group of patients. We report the use of a continuous high dose infusion of ïfosfamide at a dose of 9g/m(2) over 3 days in combination with etoposide and epirubicin followed by autologous stem cell transplant with either BEAM or Melphalan/VP16 conditioning in this difficult group. Forty six patients (28M:18F) with a median age of 28 years (range 13-45) were treated. Overall 39 out of 46 (85%) patients responded to treatment, with 17 achieving complete remission and 11 a good partial remission; 28 proceeded to autologous bone marrow/stem cell transplantation. In total, 23 patients are alive and in continuous remission with a follow up of between 12 and 61 months. Median overall survival for the whole group is 36 months. Haematological toxicity, particularly neutropenia (WHO grade IV), was observed in all cases but improved over the 3 courses of treatment in all patients. Non-haematological toxicity was not a major problem; no significant cardiac, hepatic, renal, pulmonary or neuro toxicity was observed and there were no deaths on treatment. This regime shows promise in patients with difficult Hodgkin's disease and warrants further study." @default.
• W2063600286 created "2016-06-24" @default.
• W2063600286 creator A5000091446 @default.
• W2063600286 creator A5001649295 @default.
• W2063600286 creator A5015402059 @default.
• W2063600286 creator A5020125932 @default.
• W2063600286 creator A5023179046 @default.
• W2063600286 creator A5035489508 @default.
• W2063600286 creator A5059573368 @default.
• W2063600286 creator A5070142516 @default.
• W2063600286 creator A5071176405 @default.
• W2063600286 creator A5072792214 @default.
• W2063600286 creator A5078789336 @default.
• W2063600286 creator A5081247376 @default.
• W2063600286 creator A5081308923 @default.
• W2063600286 creator A5086849223 @default.
• W2063600286 date "2000-01-01" @default.
• W2063600286 modified "2023-09-24" @default.
• W2063600286 title "High Dose Ifosfamide in Combination with Etoposide and Epirubicin Followed by Autologous Stem Cell Transplantation in the Treatment of Relapsecd/Refractory Hodgkin's Disease: a Report on Toxicity and Efficacy On behalf of the Scotland and Newcastle Lymphoma Group" @default.
• W2063600286 cites W107643022 @default.
• W2063600286 cites W1541287496 @default.
• W2063600286 cites W1825210192 @default.
• W2063600286 cites W1856398768 @default.
• W2063600286 cites W1865367030 @default.
• W2063600286 cites W1901841160 @default.
• W2063600286 cites W1989313623 @default.
• W2063600286 cites W2023165433 @default.
• W2063600286 cites W2025672320 @default.
• W2063600286 cites W2026228153 @default.
• W2063600286 cites W2030204703 @default.
• W2063600286 cites W2030404564 @default.
• W2063600286 cites W2055310422 @default.
• W2063600286 cites W2058793701 @default.
• W2063600286 cites W2074274463 @default.
• W2063600286 cites W2079197673 @default.
• W2063600286 cites W2081151946 @default.
• W2063600286 cites W2090486341 @default.
• W2063600286 cites W2104795464 @default.
• W2063600286 cites W2115919161 @default.
• W2063600286 cites W2143032361 @default.
• W2063600286 cites W2158380419 @default.
• W2063600286 cites W2163991732 @default.
• W2063600286 cites W2036215958 @default.
• W2063600286 doi "https://doi.org/10.3109/10428190009058508" @default.
• W2063600286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11042516" @default.
• W2063600286 hasPublicationYear "2000" @default.
• W2063600286 type Work @default.
• W2063600286 sameAs 2063600286 @default.
• W2063600286 citedByCount "8" @default.
• W2063600286 crossrefType "journal-article" @default.
• W2063600286 hasAuthorship W2063600286A5000091446 @default.
• W2063600286 hasAuthorship W2063600286A5001649295 @default.
• W2063600286 hasAuthorship W2063600286A5015402059 @default.
• W2063600286 hasAuthorship W2063600286A5020125932 @default.
• W2063600286 hasAuthorship W2063600286A5023179046 @default.
• W2063600286 hasAuthorship W2063600286A5035489508 @default.
• W2063600286 hasAuthorship W2063600286A5059573368 @default.
• W2063600286 hasAuthorship W2063600286A5070142516 @default.
• W2063600286 hasAuthorship W2063600286A5071176405 @default.
• W2063600286 hasAuthorship W2063600286A5072792214 @default.
• W2063600286 hasAuthorship W2063600286A5078789336 @default.
• W2063600286 hasAuthorship W2063600286A5081247376 @default.
• W2063600286 hasAuthorship W2063600286A5081308923 @default.
• W2063600286 hasAuthorship W2063600286A5086849223 @default.
• W2063600286 hasConcept C121332964 @default.
• W2063600286 hasConcept C126322002 @default.
• W2063600286 hasConcept C141071460 @default.
• W2063600286 hasConcept C142424586 @default.
• W2063600286 hasConcept C143998085 @default.
• W2063600286 hasConcept C2776694085 @default.
• W2063600286 hasConcept C2776755627 @default.
• W2063600286 hasConcept C2777408962 @default.
• W2063600286 hasConcept C2777506904 @default.
• W2063600286 hasConcept C2778119113 @default.
• W2063600286 hasConcept C2778684742 @default.
• W2063600286 hasConcept C2779050716 @default.
• W2063600286 hasConcept C2780611847 @default.
• W2063600286 hasConcept C2780835546 @default.
• W2063600286 hasConcept C28328180 @default.
• W2063600286 hasConcept C2911091166 @default.
• W2063600286 hasConcept C54355233 @default.
• W2063600286 hasConcept C71924100 @default.
• W2063600286 hasConcept C86803240 @default.
• W2063600286 hasConcept C87355193 @default.
• W2063600286 hasConcept C90924648 @default.
• W2063600286 hasConceptScore W2063600286C121332964 @default.
• W2063600286 hasConceptScore W2063600286C126322002 @default.
• W2063600286 hasConceptScore W2063600286C141071460 @default.
• W2063600286 hasConceptScore W2063600286C142424586 @default.
• W2063600286 hasConceptScore W2063600286C143998085 @default.
• W2063600286 hasConceptScore W2063600286C2776694085 @default.
• W2063600286 hasConceptScore W2063600286C2776755627 @default.
• W2063600286 hasConceptScore W2063600286C2777408962 @default.
• W2063600286 hasConceptScore W2063600286C2777506904 @default.
• W2063600286 hasConceptScore W2063600286C2778119113 @default.
• W2063600286 hasConceptScore W2063600286C2778684742 @default.
• W2063600286 hasConceptScore W2063600286C2779050716 @default.
• W2063600286 hasConceptScore W2063600286C2780611847 @default.
• W2063600286 hasConceptScore W2063600286C2780835546 @default.
• W2063600286 hasConceptScore W2063600286C28328180 @default.

• next